Vaccination with the Incidence of Post-Acute Sequelae COVID-19

Daisy Aurelia(1), Nur Upik En Masrika(2), Ismail Rahman(3),

DOI: https://doi.org/10.15294/kemas.v19i3.46447


(1) Khairun University
(2) Khairun University
(3) Khairun University

Abstract

Post-acute sequelae COVID-19 (PASC) symptoms are present in the vast majority of COVID-19 survivors, even those who have received the COVID-19 vaccine. Until now, vaccines against PASC are still controversial. Some previous findings suggest that vaccines can reduce or worsen PASC symptoms. In addition, there has been no related research in North Maluku Province, especially in Ternate City. This study aims to determine the relationship between vaccine administration and PASC based on the total dose and type of vaccine obtained using a questionnaire-based cross-sectional design questionnaire. The study population was COVID-19 patients diagnosed with RT-PCR or RDT-Ag in 2020–2022, domiciled in Ternate City. The respondents were 133 people. Bivariate analysis showed no effect of vaccine dose administration on the incidence of PASC (P=0.111). Similarly, the type and dose of vaccine based on the did not affect (first dose, P = 1.000), (second dose P = 0.732), and (booster P = 0.434) PASC. In terms of the timing of booster doses, pre- and post-COVID-19, there was no significant effect (P=0.384). However, there was a higher incidence of PASC in responders who received the booster dose post-COVID-19. There is no association between vaccine administration and the incidence of PASC.

Keywords

Vaccine; Post Acute Sequelae COVID-19; Long COVID; COVID-19; Ternate

Full Text:

PDF

References

Abdelwahab, N., Ingraham, N. E., Nguyen, N., Siegel, L., Silverman, G., Sahoo, H. S., Pakhomov, S., et al. (2022). Predictors of Postacute Sequelae of COVID-19 Development and Rehabilitation: A Retrospective Study. Archives of Physical Medicine and Rehabilitation, 103(10), 2001–2008. W.B. Saunders. Retrieved January 23, 2023, from https://www.sciencedirect.com/science/article/pii/S0003999322003975

Antonelli, M., Penfold, R. S., Merino, J., Sudre, C. H., Molteni, E., Berry, S., Canas, L. S., et al. (2022). Risk Factors and Disease Profile of Post Vaccination SARS-CoV-2 Infection in UK Users of the COVID Symptom Study app: a Prospective, Community Based, Nested, Case Control Study. The Lancet Infectious Diseases, 22, 43–55. Elsevier Ltd. Retrieved October 17, 2022, from http://www.thelancet.com/article/S1473309921004606/fulltext

Arjun, M., Singh, A. K., Pal, D., Das, K., Gajjala, A., Venkateshan, M., Mishra, B., et al. (2022). Prevalence, Characteristics, and Predictors of Long COVID among Diagnosed Cases of COVID-19. medRxiv. Retrieved from https://doi.org/10.1101/2022.01.04.21268536

Arnold, Milne, Samms E, Stadon L, Na, M., & Fw, H. (2021). Are Vaccines Safe in Patients with Long COVID? A Prospective Observational Study. Introduction. medRxiv. Retrieved from https://doi.org/10.1101/2021.03.11.21253225

Bai, F., Tomasoni, D., Falcinella, C., Barbanotti, D., Castoldi, R., Mulè, G., Augello, M., et al. (2022). Female Gender is Associated with Long COVID Syndrome: a Prospective Cohort Study. Clinical Microbiology and Infection, 28(4), 611.e9. Elsevier.

Brunvoll, S. H., Nygaard, A. B., Fagerland, M. W., Holland, P., Ellingjord-Dale, M., Dahl, J. A., & Søraas, A. (2022). Post-acute Symptoms 3-15 Months After COVID-19 Among Unvaccinated and Vaccinated Individuals with a Breakthrough Infection. International Journal of Infectious Diseases. Elsevier BV. Retrieved January 23, 2023, from https://www.ijidonline.com/article/S1201-9712(22)00596-3/fulltext

Chen, C., Haupert, S. R., Zimmermann, L., Shi, X., Fritsche, L. G., & Mukherjee, B. (2021). Global Prevalence of Post-Acute Sequelae of COVID-19 (PASC) or Long COVID: A Meta-Analysis and Systematic Review. medRxiv. Cold Spring Harbor Laboratory Press. Retrieved November 13, 2022, from https://www.medrxiv.org/content/10.1101/2021.11.15.21266377v1

COVID-19 Dashboard. (2022). Johns Hopkins University Coronavirus Resource Center. Retrieved October 16, 2022, from https://coronavirus.jhu.edu/map.html

Davis, H. E., Assaf, G. S., McCorkell, L., Wei, H., Low, R. J., Yochai, R., Redfield, S., et al. (2021). Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact. EClinicalMedicine, 38(101019), 1–19. EClinicalMedicine. Retrieved October 17, 2022, from https://pubmed.ncbi.nlm.nih.gov/34308300/

Dinas Kesehatan Kota Ternate. (2022). Kasus COVID-19 Kota Ternate. Dinas Kesehatan Kota Ternate.

Masrika N., Hasan, M., Yusran, Y., & Buyung, S. (2022). Karakteristik Pasien COVID-19 di Rumah Sakit Umum Daerah Dr. H. Chasan Boesoirie. JUMANTIK (Jurnal Ilmiah Penelitian Kesehatan), 7(3), 255–265. UIN Sumatera Utara Medan. Retrieved May 17, 2023, from http://jurnal.uinsu.ac.id/index.php/kesmas/article/view/11676

Global Situation Report. (2022, September 22). Coronavirus Disease 2019 (COVID-19) : Situation Report-94. World Health Organization. Retrieved October 12, 2022, from https://www.who.int/indonesia/news/novel-coronavirus/situation-reports

Hayes, L. D., Ingram, J., & Sculthorpe, N. F. (2021). More Than 100 Persistent Symptoms of SARS-CoV-2 (Long COVID): A Scoping Review. Frontiers in medicine, 8(750378). Front Med (Lausanne). Retrieved October 17, 2022, from https://pubmed.ncbi.nlm.nih.gov/34790680/

Herman, B., Viwattanakulvanid, P., Dzulhadj, A., Oo, A. C., Patricia, K., & Pongpanich, S. (2022). Effect of Full Vaccination and Post-COVID Olfactory Dysfunction in Recovered COVID-19 Patient. A Retrospective Longitudinal Study with Propensity Matching. medRxiv, 2022.01.10.22269007. Cold Spring Harbor Laboratory Press. Retrieved October 15, 2022, from https://www.medrxiv.org/content/10.1101/2022.01.10.22269007v1

Hoque, A., Rahman, M. M., Imam, H., Nahar, N., & Chowdhury, F. U. H. (2021). Third Dose Vaccine with BNT162b2 and its Response on Long COVID After Breakthrough Infections. medRxiv. Cold Spring Harbor Laboratory Press. Retrieved October 17, 2022, from https://www.medrxiv.org/content/10.1101/2021.11.08.21266037v1

Imam, S. A., Lao, W. P., Reddy, P., Nguyen, S. A., & Schlosser, R. J. (2020, November 1). Is SARS-CoV-2 (COVID-19) Postviral Olfactory Dysfunction (PVOD) Different from other PVOD? World Journal of Otorhinolaryngology - Head and Neck Surgery. KeAi Communications Co. Retrieved January 22, 2023, from https://pubmed.ncbi.nlm.nih.gov/32837756/

Infeksi Emerging. (2022). Perkembangan Situasi Penyakit Infeksi Emerging Minggu ke-38 Tahun 2022. Kementerian Kesehatan Republik Indonesia. Retrieved November 25, 2022, from https://infeksiemerging.kemkes.go.id/document/perkembangan-situasi-penyakit-infeksi-emerging-minggu-epidemiologi-ke-45-tahun-2022/view

Leon, S. L., Ostrosky, T. W., Perelman, C., Sepulveda, R., Rebolledo, P. A., Cuapio, A., & Villapol, S. (2021). More Than 50 Long-Term Effects of COVID-19: a Systematic Review and Meta-analysis. Scientific Reports, 11(16144), 1–12. Retrieved from https://doi.org/10.1038/s41598-021-95565-8

Lerner, A. M., Robinson, D. A., Yang, L., Williams, C. F., Newman, L. M., Breen, J. J., Eisinger, R. W., et al. (2021). Toward Understanding COVID-19 Recovery: National Institutes of Health Workshop on Post Acute COVID-19. Annals of Internal Medicine, 174(7), 999–1003. American College of Physicians . Retrieved October 17, 2022, from https://www.acpjournals.org/doi/10.7326/M21-1043

Logue, J. K., Franko, N. M., McCulloch, D. J., McConald, D., Magedson, A., Wolf, C. R., & Chu, H. Y. (2021). Sequelae in Adults at 6 Months After COVID-19 Infection. JAMA Network Open, 4(2), 1–4. American Medical Association. Retrieved October 17, 2022, from https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2776560

Madabhavi, I., Sarkar, M., & Kadakol, N. (2020). COVID-19: a Review. Monaldi Archives for Chest Disease, 90(1298), 248–258. PAGEPress Publications. Retrieved October 13, 2022, from https://monaldi-archives.org/index.php/macd/article/view/1298

Nehme, M., Braillard, O., Salamun, J., Jacquerioz, F., Courvoisier, D. S., Spechbach, H., & Guessous, I. (2022). Symptoms After COVID-19 Vaccination in Patients with Post-Acute Sequelae of SARS-CoV-2. Journal of General Internal Medicine, 37(6), 1585–1588. Springer. Retrieved October 15, 2022, from https://link.springer.com/article/10.1007/s11606-022-07443-2

Notarte, K. I., Catahay, J. A., Velasco, J. V., Pastrana, A., Ver, A. T., Pangilinan, F. C., Peligro, P. J., et al. (2022). Impact of COVID-19 Vaccination on the Risk of Developing Long-COVID and on Existing Long-COVID Symptoms: A Systematic Review. eClinicalMedicine, 53. Elsevier Ltd. Retrieved September 28, 2022, from http://www.thelancet.com/article/S2589537022003546/fulltext

Rudroff, T., Workman, C. D., & Bryant, A. D. (2022). Potential Factors That Contribute to Post-COVID-19 Fatigue in Women. Brain Sciences, 12(5). MDPI. Retrieved January 22, 2023, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139370/

Shi, Y., Wang, G., Cai, X., Deng, J., Zheng, L., Zhu, H., Zheng, M., et al. (2020). An Overview of COVID-19. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 21(5), 343–360. Retrieved October 12, 2022, from https://doi.org/10.1631/jzus.B2000083

Shukla, A. K., & Misra, S. (2022). An Overview of Post COVID Sequelae. Journal of Basic and Clinical Physiology and Pharmacology, 33(6), 715–726. De Gruyter Open Ltd. Retrieved November 27, 2022, from https://www.degruyter.com/document/doi/10.1515/jbcpp-2022-0057/html

Simon, M. A., Luginbuhl, R. D., & Parker, R. (2021). Reduced Incidence of Long-COVID Symptoms Related to Administration of COVID-19 Vaccines Both Before COVID-19 Diagnosis and Up to 12 Weeks After. medRxiv, 2021.11.17.21263608. Cold Spring Harbor Laboratory Press. Retrieved October 15, 2022, from https://www.medrxiv.org/content/10.1101/2021.11.17.21263608v1

Sudre, C. H., Murray, B., Varsavsky, T., Graham, M. S., Penfold, R. S., Bowyer, R. C., Pujol, J. C., et al. (2021). Attributes and Predictors of Long COVID. Nature Medicine, 27, 626–631. Nature Publishing Group. Retrieved October 17, 2022, from https://doi.org/10.1038/s41591-021-01292-y

Susanto, A. D., Isbaniah, F., Pratomo, I. P., Antariksa, B., Samoedro, E., Taufik, M., Harinda, F., et al. (2022). Clinical Characteristics and Quality of Life of Persistent Symptoms of COVID-19 Syndrome in Indonesia. GERMS, 12(2), 158–168. Retrieved from www.germs.ro

Tenforde, M. W., Kim, S. S., Lindsell, C. J., Rose, B. E., Shapiro, N. I., Files, D. C., Gibbs, K. W., et al. (2020). Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020. Morbidity and Mortality Weekly Report, 69(30), 993–998. Centers for Disease Control MMWR Office. Retrieved October 17, 2022, from https://www.cdc.gov/mmwr/volumes/69/wr/mm6930e1.htm

Tran, V. T., Porcher, R., Pane, I., & Ravaud, P. (2022). Course of Post COVID-19 Disease Symptoms Over Time in the ComPaRe Long COVID Prospective e-Cohort. Nature communications, 13(1812), 1–6. Nat Commun. Retrieved October 17, 2022, from https://pubmed.ncbi.nlm.nih.gov/35383197/

Tran, V.-T., Perrodeau, E., Saldanha, J., Pane, I., & Ravaud, P. (2021). Efficacy of COVID-19 Vaccination on the Symptoms of Patients With Long COVID: A Target Trial Emulation Using Data From the ComPaRe e-Cohort in France. SSRN Electronic Journal. Elsevier BV.

Tsuchida, T., Hirose, M., Inoue, Y., Kunishima, H., Otsubo, T., & Matsuda, T. (2022). Relationship between Changes in Symptoms and Antibody Titers After a Single Vaccination in Patients with Long COVID. Journal of Medical Virology, 94(7), 3416–3420. John Wiley & Sons, Ltd. Retrieved November 22, 2022, from DOI: 10.1002/jmv.27689

Wang, K., Wang, L., Li, M., Xie, B., He, L., Wang, M., Zhang, R., et al. (2022). Real Word Effectiveness of Global COVID-19 Vaccines Against SARS-CoV-2 Variants: A Systematic Review and Meta-Analysis. Frontiers in Medicine, 9. Frontiers Media S.A. Retrieved October 16, 2022, from /pmc/articles/PMC9160927/

Wisnivesky, J. P., Govindarajulu, U., Bagiella, E., Goswami, R., Kale, M., Campbell, K. N., Meliambro, K., et al. (2022). Association of Vaccination with the Persistence of Post-COVID Symptoms. Journal of General Internal Medicine, 37(7), 1748–1753. Springer. Retrieved October 14, 2022, from https://link.springer.com/article/10.1007/s11606-022-07465-w

Wynberg, E., Han, A. X., Boyd, A., van Willigen, H. D. G., Verveen, A., Lebbink, R., van der Straten, K., et al. (2022). The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study. Vaccine, 40(32), 4424–4431. Elsevier.

Zheng, C., Shao, W., Chen, X., Zhang, B., Wang, G., & Zhang, W. (2022). Real World Effectiveness of COVID-19 Vaccines: a Literature Review and Meta-analysis. International journal of infectious diseases, 114, 252–260. Int J Infect Dis. Retrieved October 16, 2022, from https://pubmed.ncbi.nlm.nih.gov/34800687/

Refbacks

  • There are currently no refbacks.


Bookmark and Share


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.